Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-26
1999-11-02
Powers, Fiona T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514359, 514406, 514414, 514415, 5142345, 514253, 514318, 514322, 544124, 544132, 544139, 544140, 544144, 544364, 544366, 544370, 544371, 544373, 546194, 546199, 5462684, 5462734, 5462757, 5462774, C07D41310, A61K 3140
Patent
active
059771542
ABSTRACT:
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formulas I and II: ##STR1##
REFERENCES:
patent: 4032575 (1977-06-01), Ikezaki et al.
patent: 4288452 (1981-09-01), Sombroek et al.
patent: 4309443 (1982-01-01), Smith et al.
patent: 4338333 (1982-07-01), Ainsworth et al.
patent: 4367235 (1983-01-01), Ross et al.
patent: 4385066 (1983-05-01), Ainsworth et al.
patent: 4391826 (1983-07-01), Mills et al.
patent: 4396627 (1983-08-01), Ainsworth et al.
patent: 4432993 (1984-02-01), Ferris
patent: 4478849 (1984-10-01), Ainsworth et al.
patent: 4497813 (1985-02-01), Ostermayer et al.
patent: 4503067 (1985-03-01), Wiedemann et al.
patent: 4636511 (1987-01-01), Ostermayer et al.
patent: 4652679 (1987-03-01), Alig et al.
patent: 4697022 (1987-09-01), Leinert
patent: 4727067 (1988-02-01), Ostermayer et al.
patent: 4751246 (1988-06-01), Philion
patent: 4772631 (1988-09-01), Holloway et al.
patent: 4940800 (1990-07-01), Bertolini et al.
patent: 4977148 (1990-12-01), Holloway et al.
patent: 5013761 (1991-05-01), Beedle et al.
patent: 5321036 (1994-06-01), Sher
patent: 5393772 (1995-02-01), Yue et al.
patent: 5420294 (1995-05-01), Beedle et al.
patent: 5453436 (1995-09-01), Ohlstein
patent: 5534640 (1996-07-01), Tegeler et al.
patent: 5541197 (1996-07-01), Fisher et al.
patent: 5541204 (1996-07-01), Sher et al.
patent: 5561142 (1996-10-01), Fisher et al.
Bell Michael Gregory
Droste Christine Ann
Jesudason Cynthia Darshini
Rito Christopher John
Shuker Anthony John
Davis Steven G.
Eli Lilly and Company
Powers Fiona T.
LandOfFree
Selective .beta.3 adrenergic agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective .beta.3 adrenergic agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective .beta.3 adrenergic agonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2136014